A Nobel Winner’s New Plan to Scale Personalized Gene Therapy
CRISPR pioneer Jennifer Doudna has co-founded a startup, Aurora Therapeutics, to create tailored gene-editing treatments for rare diseases. Their strategy hinges on a new FDA regulatory pathway that could dramatically speed up approvals.